Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review

Buckley, Brian S; Harreiter, Jürgen; Damm, Peter; Corcoy, Rosa; Chico, Ana; Simmons, David; Vellinga, Akke; Dunne, Fidelma

doi:10.1111/j.1464-5491.2011.03541.x

Cited by 322 publications

(269 citation statements)

References 56 publications

Supporting

Mentioning

230

Contrasting

Unclassified

Order By: Relevance

“…A recent review also shows that screening and management of GDM is very variable across Europe, partly due to the ongoing controversy and inadequate clinician awareness of GDM [23]. A recent survey performed in the northern part of Belgium highlights that policies are often also inconsistent even within one region [24].…”

Section: An Ebcog Initiative To Develop a Proposal For The Use Of Unimentioning

confidence: 99%

A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

et al. 2015

View full text Add to dashboard Cite

Screening and diagnostic criteria for gestational diabetes (GDM) are inconsistent across Europe, and the development of a uniform GDM screening strategy is necessary. Such a strategy would create opportunities for more women to receive timely treatment for GDM. Developing a consensus on screening for GDM in Europe is challenging, as populations are diverse and healthcare delivery systems also differ. The European Board & College of Obstetrics and Gynaecology (EBCOG) has responded to this challenge by appointing a steering committee, including members of the EBCOG and the Diabetic Pregnancy Study Group (DPSG) associated with the EASD, to develop a proposal for the use of uniform diagnostic criteria for GDM in Europe. A proposal has been developed and has now been approved by the Council of the EBCOG. The current proposal is to screen for overt diabetes at the first prenatal contact using cut-off values for diabetes outside pregnancy, with particular efforts made to screen high-risk groups. When screening for GDM is performed at 24 weeks' gestation or later, the proposal is now to use the 75 g OGTT with the new WHO diagnostic criteria for GDM. However, more research is necessary to evaluate the best GDM screening strategy for different populations in Europe. Therefore, no clear recommendation has been made on whether a universal one-step, two-step or a risk-factorbased screening approach should be used. The use of the same WHO diagnostic GDM criteria across Europe will be an important step towards uniformity.

show abstract

Section: An Ebcog Initiative To Develop a Proposal For The Use Of Unimentioning

confidence: 99%

A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Also, offspring of mothers with GDM have increased risk of obesity and diabetes later in life [6,7]. Globally, the prevalence of GDM has increased within the last 20 years [8,9]. The first study of GDM performed in Greenland reported a very low prevalence of GDM among women from Nuuk who gave birth in 2008 [10].…”

Section: Introductionmentioning

confidence: 99%

Gestational diabetes and macrosomia among Greenlanders. Time to change diagnostic strategy?

Pedersen

Lind

Abelsen

et al. 2018

International Journal of Circumpolar Health

View full text Add to dashboard Cite

Gestational diabetes mellitus (GDM) is a serious condition associated to both maternal and offspring complications. Yet, no globally accepted consensus exists on how to test and diagnose GDM. In Greenland, the clinical criteria for testing and diagnosing GDM are adapted from Danish guidelines. The aim of this study was to estimate the prevalence of GDM among Greenlanders using both the current clinical GDM criteria and the recent WHO 2013 criteria and, further, to study the association between GDM, pre-pregnant overweight or obesity and macrosomia. A cross-sectional study of all 450 Greenlandic women who gave birth to a singleton in Nuuk within 1 year was performed. Based on an oral glucose tolerance test measuring capillary whole blood glucose, 119 women were categorised as having clinical GDM, WHO 2013 GDM or not GDM. Macrosomia defined as birth weight above 4,000 g was used as outcome variable. The prevalence of clinical GDM and WHO 2013 GDM was 0.4% (95% CI; 0–1.1) and 6.9% (95% CI; 4.5–9.2). WHO 2013 GDM, fasting blood glucose, pre-pregnant maternal overweight and obesity were associated with macrosomia. WHO 2013 GDM criteria were superior to clinical criteria in predicting macrosomia indicating that it may be time to consider the diagnostic strategy used in Greenland. Pre-pregnant overweight may also need more intensified lifestyle-intervention.Abbreviations: GDM: Gestational diabetes mellitus; VP: venous plasma; CWB: capillary whole blood; OGTT: oral glucose tolerance test; WHO: World Health Organisation; FIGO: The International Federation of Gynaecology and Obstetrics; BMI: body mass index; GA: gestational age

show abstract

“…The same can be done at undergraduate and postgraduate levels by curriculum planners. Similar campaigns are underway in Europe as well [9].…”

mentioning

confidence: 95%

Gestational diabetes mellitus: from thought to action

Kalra

2014

Int J Diabetes Dev Ctries

View full text Add to dashboard Cite

Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review

Cited by 322 publications

References 56 publications

A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

Gestational diabetes and macrosomia among Greenlanders. Time to change diagnostic strategy?

Gestational diabetes mellitus: from thought to action

Contact Info

Product

Resources

About